Total Payments
$2,340
2024 Payments
$147.83
Companies
13
Transactions
32
Medicare Patients
3,006
Medicare Billing
$324,141
Payment Breakdown by Category
Food & Beverage$2,305 (98.5%)
Education$34.30 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,305 | 28 | 98.5% |
| Education | $34.30 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $518.71 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $479.24 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $352.97 | 3 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $229.61 | 2 | $0 (2020) |
| Acerta Pharma LLC | $125.00 | 1 | $0 (2021) |
| Amgen Inc. | $125.00 | 1 | $0 (2021) |
| US WorldMeds, LLC | $124.15 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $113.89 | 1 | $0 (2018) |
| ABBVIE INC. | $109.20 | 2 | $0 (2022) |
| PFIZER INC. | $88.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.83 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($147.83) |
| 2023 | $129.99 | 3 | GlaxoSmithKline, LLC. ($110.60) |
| 2022 | $457.57 | 6 | AstraZeneca Pharmaceuticals LP ($240.31) |
| 2021 | $402.20 | 5 | GlaxoSmithKline, LLC. ($135.58) |
| 2020 | $262.34 | 3 | Teva Pharmaceuticals USA, Inc. ($133.46) |
| 2019 | $551.91 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($242.00) |
| 2018 | $387.69 | 6 | US WorldMeds, LLC ($124.15) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.49 | General |
| 02/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $11.67 | General |
| Category: DIABETES | ||||||
| 02/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $11.67 | General |
| Category: DIABETES | ||||||
| 03/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Endocrinology | ||||||
| 01/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $90.60 | General |
| 01/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 11/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $83.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $96.41 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $115.02 | General |
| Category: Respiratory | ||||||
| 03/02/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.29 | General |
| Category: Respiratory | ||||||
| 11/10/2021 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/10/2021 | Acerta Pharma LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | Medtronic, Inc. | 3F (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Heart Valves | ||||||
| 03/10/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $133.46 | General |
| Category: Central Nervous System | ||||||
| 02/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Education | In-kind items and services | $3.88 | General |
| Category: DIABETES | ||||||
| 01/30/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $88.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $7.08 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $109.92 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 405 | 479 | $171,733 | $47,712 |
| 2022 | 19 | 1,059 | 1,429 | $422,518 | $120,432 |
| 2021 | 15 | 927 | 1,296 | $392,925 | $103,374 |
| 2020 | 15 | 615 | 873 | $256,775 | $52,624 |
Total Patients
3,006
Total Services
4,077
Medicare Billing
$324,141
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 194 | $80,898 | $17,152 | 21.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 41 | 41 | $41,410 | $11,516 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $9,882 | $9,329 | 94.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 107 | $33,277 | $6,508 | 19.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $1,558 | $1,488 | 95.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 22 | 22 | $3,850 | $1,064 | 27.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $858.00 | $655.20 | 76.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 400 | $166,800 | $38,933 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 225 | 339 | $105,429 | $24,968 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 119 | 119 | $19,278 | $18,342 | 95.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 47 | 47 | $43,005 | $13,125 | 30.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 59 | $13,334 | $4,041 | 30.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 24 | 24 | $10,464 | $3,202 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $12,179 | $2,936 | 24.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 70 | 71 | $7,477 | $2,584 | 34.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 60 | $4,776 | $2,164 | 45.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 45 | 45 | $7,875 | $2,152 | 27.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 27 | 42 | $2,772 | $2,121 | 76.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $8,900 | $1,880 | 21.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 32 | $6,144 | $1,505 | 24.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 13 | $4,134 | $736.96 | 17.8% |
| 0053A | Adm sarscv2 30mcg trs-sucr 3 | Office | 2022 | 14 | 14 | $2,450 | $669.48 | 27.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 41 | $4,141 | $566.56 | 13.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 20 | $2,140 | $258.04 | 12.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 12 | 12 | $960.00 | $200.79 | 20.9% |
About Dr. David Chee, MD
Dr. David Chee, MD is a Internal Medicine healthcare provider based in Pleasanton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306846373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chee, MD has received a total of $2,340 in payments from pharmaceutical and medical device companies, with $147.83 received in 2024. These payments were reported across 32 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,305).
As a Medicare-enrolled provider, Chee has provided services to 3,006 Medicare beneficiaries, totaling 4,077 services with total Medicare billing of $324,141. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pleasanton, CA
- Active Since 07/29/2005
- Last Updated 11/19/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306846373
Products in Payments
- TRELEGY ELLIPTA (Drug) $368.64
- OFEV (Drug) $250.00
- ELIQUIS (Drug) $202.65
- JARDIANCE (Drug) $137.14
- AJOVY (Biological) $133.46
- FASENRA (Biological) $125.29
- Xadago (Drug) $124.15
- BREZTRI (Drug) $115.02
- BEVESPI AEROSPHERE (Drug) $112.66
- UBRELVY (Drug) $109.20
- AJOVY (Drug) $96.15
- DALVANCE (Drug) $36.99
- Dexcom G6 Transmitter (Medical Supply) $19.39
- 3F (Device) $16.62
- SPIRIVA RESPIMAT (Drug) $7.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pleasanton
Rishi Sawhney, M.d, M.D
Internal Medicine — Payments: $305,444
Internal Medicine $305,444
David Tehrani, Md, MD
Internal Medicine — Payments: $17,552
Internal Medicine $17,552
Dr. Aman Saw, M.d, M.D
Internal Medicine — Payments: $7,660
Internal Medicine $7,660
Donald Lai, Md, MD
Internal Medicine — Payments: $4,656
Internal Medicine $4,656
Calvin Lei, Md, MD
Internal Medicine — Payments: $3,233
Internal Medicine $3,233
Jennifer Fuh, Do, DO
Internal Medicine — Payments: $2,996
Internal Medicine $2,996